1.
Mounier N, El Gnaoui T, Tilly H, Canioni D, Sebban C, Casasnovas R-O, Delarue R, Sonet A, Beaussart P, Petrella T, Castaigne S, Bologna S, Salles G, Rahmouni A, Gaulard P, Haioun C. Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial. Haematologica 2013; 98(11):1726-1731; https://doi.org/10.3324/haematol.2013.090597.